- Assistant Professor
- Office: 265A
- Phone: 401.874.4739
- Email: email@example.com
- Office Location: 7 Greenhouse Road, Kingston, RI 02881
Dr. Ashley Buchanan is an Assistant Professor of Pharmacy Practice, specializing in the areas of Biostatistics and Epidemiology. She brings over nine years of experience collaborating on HIV/AIDS research working closely with colleagues both domestically and internationally to develop and apply causal methodology to improve treatment and prevention of HIV/AIDS.
Causal inference; Generalizability; Interference; HIV/AIDS; Substance Use Disorder Treatment and Prevention; Randomized trials; Observational studies; Survival analysis; Longitudinal analysis; Network Science
Postdoctoral Research Fellow, Harvard T.H. Chan School of Public Health, 2016
DrPH, University of North Carolina at Chapel Hill, 2015
MS, Harvard University, 2007
BS, University of Massachusetts, Amherst, 2005
Buchanan, A, Hudgens, M, Cole S. “Generalizing evidence from HIV trials using inverse sampling weights”. In: Quantitative Methods for HIV/AIDS Research, In Press (2016).
Lesko C, Buchanan A, Westreich D, Edwards J, Hudgens, M, Cole S. Practical considerations when generalizing study results: a potential outcomes perspective. Epidemiology, In Press (2016)
Buchanan A, Hudgens MG, Cole SR, Lau B, Adimora AA. Worth the weight: using inverse probability weighted Cox models in AIDS research. AIDS Research and Human Retroviruses. 2014;30(12):1170-7. PMCID: PMC4250953.
Achenbach CJ, Buchanan A, Cole SR, Hou L, Mugavero MJ, Crane HM, Moore RD, Haubrich RH, Gopal S, Eron JJ, Hunt PW, Rodriguez B, Mayer K, Saag MS, Kitahata MM. HIV viremia and incidence of non-Hodgkin lymphoma in patients successfully treated with antiretroviral therapy. Clinical Infectious Diseases. 2014;58(11):1599-606. PMCID: PMC4017888.
Zhou Z, Yu F, Buchanan A, Fu Y, Campos M, Wu KK, Chambless LE, Folsom AR, Boerwinkle E, Dong JF. Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts. PLoS One. 2014;9(1):e84810. PMCID: PMC3894939.
Rice ML, Zeldow B, Siberry GK, Purswani M, Malee K, Hoffman HJ, Frederick T, Buchanan A, Sirois PA, Allison SM, Williams PL. Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants. The Pediatric Infectious Disease Journal. 2013;32(10):e406-13. PMCID: PMC3785009.
Rice ML, Buchanan A, Siberry GK, Malee KM, Zeldow B, Frederick T, Purswani MU, Hoffman HJ, Sirois PA, Smith R, Torre P, 3rd, Allison SM, Williams PL. Language impairment in children perinatally infected with HIV compared to children who were HIV-exposed and uninfected. J Dev Behav Pediatr. 2012;33(2):112-23. PMCID: PMC3310927.
Torre P, Zeldow B, Hoffman HJ, Buchanan A, Siberry GK, Rice M, Sirois PA, Williams PL. Hearing loss in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents. The Pediatric Infectious Disease Journal. 2012;31(8):835-41. PMCID: PMC3410657.
Buchanan A, Montepiedra G, Sirois PA, Kammerer B, Garvie PA, Storm DS, Nichols SL. Barriers to medication adherence in HIV-infected children and youth based on self- and caregiver report. Pediatrics. 2012;129(5):e1244-51. PMCID: PMC3340587.
Campos M, Buchanan A, Yu F, Barbalic M, Xiao Y, Chambless LE, Wu KK, Folsom AR, Boerwinkle E, Dong JF. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. Blood. 2012;119(8):1929-34. PMCID: PMC3293647.
Argiris A, Buchanan A, Brockstein B, Kolesar J, Ghebremichael M, Pins M, et al. Docetaxel and irinotecan in recurrent or metastatic head and neck cancer. Cancer. 2009;115(19):4504-13. PMCID: PMC2749918